Time to Deal with Rheumatoid Cachexia: Prevalence, Diagnostic Criteria, Treatment Effects and Evidence for Management
Open Access
- 30 September 2022
- journal article
- research article
- Published by Convin SA in Mediterranean Journal of Rheumatology
- Vol. 33 (3) , 271-290
Abstract
Cachexia is an early result of rheumatoid arthritis (RA) (rheumatoid cachexia, RC), characterised mainly by involuntary loss of fat-free mass. RC is apparent in 1–67% of patients with RA, depending on the diagnostic criteria applied and the method used for the assessment of body composition. RC is associated with increased inflammation and disability, lower health perception, and greater mortality risk. These changes in body composition are driven by the inflammation process, the low levels of physical activity, the underlying testosterone deficiency and hypogonadism, and the pharmacotherapy required for RA. Chronic inflammation enhances resting energy expenditure as a response to stress, inducing an energy deficit, further propelling protein turnover. The use of corticosteroids and tumour necrosis factor α (TNF-α) inhibitors tend to increase fat accumulation, whereas other disease-modifying antirheumatic drugs (DMARDs) appear to induce increments in fat-free mass. The present review presents all information regarding the prevalence of RC, diagnostic criteria, and comorbidities, as well as the effects of pharmacotherapy and medical nutrition therapy on body composition of patients with RA.Keywords
This publication has 118 references indexed in Scilit:
- Energy metabolism and rheumatic diseases: from cell to organismArthritis Research & Therapy, 2012
- Low level of physical activity in women with rheumatoid arthritis is associated with cardiovascular risk factors but not with body fat mass - a cross sectional studyBMC Musculoskeletal Disorders, 2011
- Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 monthsArthritis Research & Therapy, 2010
- Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional studyArthritis Research & Therapy, 2009
- Association of body composition with disability in rheumatoid arthritis: Impact of appendicular fat and lean tissue massArthritis Care & Research, 2008
- Abnormal body composition phenotypes in older rheumatoid arthritis patients: Association with disease characteristics and pharmacotherapiesArthritis Care & Research, 2008
- Rheumatoid cachexia: a clinical perspectiveRheumatology, 2008
- Redefining overweight and obesity in rheumatoid arthritis patientsAnnals of the Rheumatic Diseases, 2007
- Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventionsRheumatology, 2004
- Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation.Journal of Clinical Investigation, 1994